Vyome Holdings, Inc SEC filings HIND
Vyome Holdings, Inc has 693 filings in SEC EDGAR's recent list, going back to Feb 13, 2008. Its latest annual report, Form 10-K, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 28, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 425 | Filing | Jul 30, 2025 | — |
| 425 | Filing | Jul 25, 2025 | — |
| 425 | Filing | Jul 24, 2025 | — |
| 425 | Filing | Jul 24, 2025 | — |
| 425 | Filing | Jul 21, 2025 | — |
| 425 | Filing | Jul 18, 2025 | — |
| 425 | Filing | Jul 15, 2025 | — |
| 425 | Filing | Jun 26, 2025 | — |
| EFFECT | Filing | Jun 20, 2025 | — |
| NT 10-Q | Form nt 10-q | May 15, 2025 | Mar 31, 2025 |
| EFFECT | Filing | May 14, 2025 | — |
| EFFECT | Filing | May 14, 2025 | — |
| CORRESP | Letter to the SEC | May 14, 2025 | — |
| CORRESP | Letter to the SEC | May 13, 2025 | — |
| UPLOAD | Letter from the SEC | May 7, 2025 | — |
| DRS | Filing | May 2, 2025 | — |
| CORRESP | Letter to the SEC | Apr 28, 2025 | — |
| 425 | Filing | Apr 21, 2025 | — |
| NT 10-K | Filing | Apr 1, 2025 | Dec 31, 2024 |
| UPLOAD | Letter from the SEC | Mar 14, 2025 | — |
| PRER14A | Filing | Mar 13, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2025 | — |
| EFFECT | Filing | Feb 14, 2025 | — |
| EFFECT | Filing | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 13, 2025 | — |
| CORRESP | Letter to the SEC | Feb 12, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 12, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 31, 2025 | — |
| CORRESP | Letter to the SEC | Jan 14, 2025 | — |
| CORRESP | Letter to the SEC | Jan 14, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 3, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2024 | — |
| 425 | Filing | Dec 11, 2024 | — |
| CORRESP | Letter to the SEC | Dec 5, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2024 | — |
| 425 | Filing | Aug 28, 2024 | — |
| 425 | Filing | Aug 28, 2024 | — |
| 425 | Filing | Jul 9, 2024 | — |
| RW | Filing | Jun 21, 2024 | — |
| EFFECT | Filing | Sep 29, 2023 | — |
| CORRESP | Letter to the SEC | Sep 28, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2023 | — |
| NT 10-K | Filing | Apr 3, 2023 | Dec 31, 2022 |
| EFFECT | Filing | Feb 3, 2023 | — |
| CORRESP | Letter to the SEC | Feb 3, 2023 | — |
| CORRESP | Letter to the SEC | Feb 3, 2023 | — |
| RW WD | Filing | Feb 3, 2023 | — |
| RW | Filing | Feb 2, 2023 | — |
| RW | Filing | Feb 2, 2023 | — |
| CORRESP | Letter to the SEC | Feb 1, 2023 | — |
| CORRESP | Letter to the SEC | Feb 1, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 20, 2023 | — |
| NT 10-Q | Filing | Aug 16, 2022 | Jun 30, 2022 |
| NT 10-Q | Filing | May 13, 2022 | Mar 31, 2022 |
| NT 10-K | Filing | Apr 1, 2022 | Dec 31, 2021 |
| EFFECT | Filing | Sep 17, 2021 | — |
| EFFECT | Filing | Sep 17, 2021 | — |
| CORRESP | Letter to the SEC | Sep 15, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2021 | — |
| 425 | Form 8-k | May 21, 2021 | — |
| 425 | Form 8-k | May 18, 2021 | — |
| 425 | Filing | May 18, 2021 | — |
| 425 | Form 8-k | May 13, 2021 | — |
| 425 | Filing | May 4, 2021 | — |
| EFFECT | Filing | Apr 13, 2021 | — |
| CORRESP | Letter to the SEC | Apr 9, 2021 | — |
| 425 | 8-k | Jan 20, 2021 | — |
| 425 | 8-k | Jan 20, 2021 | — |
| EFFECT | Filing | Feb 28, 2020 | — |
| CORRESP | Letter to the SEC | Feb 27, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 14, 2020 | — |
| EFFECT | Filing | Aug 1, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 1, 2019 | — |
| CORRESP | Letter to the SEC | Aug 1, 2019 | — |
| CORRESP | Letter to the SEC | Jul 30, 2019 | — |
| CORRESP | Letter to the SEC | Jul 30, 2019 | — |
| CORRESP | Letter to the SEC | Jul 17, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2019 | — |
| EFFECT | Filing | Feb 13, 2019 | — |
| CORRESP | Letter to the SEC | Feb 11, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2019 | — |
| EFFECT | Filing | Sep 14, 2018 | — |
| CORRESP | Letter to the SEC | Sep 12, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2018 | — |
| DEL AM | Filing | Sep 4, 2018 | — |
| D | Filing | Aug 29, 2018 | — |
| EFFECT | Filing | Nov 17, 2017 | — |
| CORRESP | Letter to the SEC | Nov 17, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2017 | — |
| CT ORDER | Filing | Nov 7, 2016 | — |
| EFFECT | Filing | Oct 5, 2016 | — |
| CERTNAS | Auto-generated paper document | Oct 3, 2016 | — |
| CORRESP | Letter to the SEC | Oct 3, 2016 | — |
| CORRESP | Letter to the SEC | Oct 3, 2016 | — |
| 8-A12B | Filing | Sep 27, 2016 | — |
| CORRESP | Letter to the SEC | Sep 26, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2016 | — |
| CORRESP | Letter to the SEC | Sep 16, 2016 | — |
| CORRESP | Letter to the SEC | Sep 8, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2016 | — |
| DRS | Filing | Aug 4, 2016 | — |
| D | Filing | Oct 2, 2014 | — |
| D | Filing | Dec 19, 2012 | — |
| D | Filing | May 17, 2012 | — |
| D | Filing | Mar 26, 2012 | — |
| REGDEX | Auto-generated paper document | Feb 13, 2008 | — |
Showing 107 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HIND (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Clemente, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1427570
- Former names
- ReShape Lifesciences Inc. (until Aug 14, 2025); OBALON THERAPEUTICS INC (until Jun 21, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.